Plain-English translation of NCT07237048 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Stroke research guide โPhase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Stroke is a serious medical emergency that can cause lasting damage to the brain. This study is testing whether a medication called minocycline โ a low-cost antibiotic with protective properties โ can help people recover better when given right after a stroke. Researchers hope this medication, combined with standard stroke care, will reduce disability and improve survival.
While doctors have good treatments for some types of strokes, there are still limited ways to protect the brain after a stroke happens. Early studies have suggested that this medication might help, but a large, rigorous study has never proven whether it truly works.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to either receive the medication or standard stroke care alone. If you receive the medication, you will take one dose by mouth each day for five days while in the hospital. Doctors will measure how well you are recovering at hospital discharge, at 30 days, and at 90 days after your stroke using standardized assessments.
AI-generated summary from trial data ยท Aug 9, 2026 ยท Not medical advice
United States
Phase
Large-scale testing
Sponsor
Joyce Chen
Enrollment target
~1,164 participants
Started
February 2026
Primary completion
December 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Qingliang T. Wang, MD, PhD
Maimonides Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.